Registry for patients with acute heart failure
Prospective Registry of Acute Heart Failure
This study is creating a registry of people hospitalized for acute heart failure to learn more about their symptoms and health conditions, which could help improve treatment and care for future patients.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1200 (estimated) |
| Ages | 16 Years to 100 Years |
| Sex | All |
| Sponsor | University Hospital, Geneva Academic / other |
| Locations | 1 site (Geneva) |
| Trial ID | NCT02444416 on ClinicalTrials.gov |
What this trial studies
This observational study aims to create a registry of patients hospitalized for acute heart failure to better understand the diverse etiologies, clinical presentations, and co-morbidities associated with this condition. By collecting data on patients' symptoms, signs, and biomarkers such as brain natriuretic peptide levels, the study seeks to identify prognostic factors that influence outcomes. The findings could help tailor treatment strategies and improve patient management in acute heart failure cases.
Who should consider this trial
Good fit: Ideal candidates for this study are patients experiencing acute heart failure symptoms requiring urgent treatment.
Not a fit: Patients who are unable or refuse to consent to participate in the study will not benefit from this research.
Why it matters
Potential benefit: If successful, this study could lead to improved understanding and management of acute heart failure, potentially reducing morbidity and mortality rates.
How similar studies have performed: While similar observational studies have been conducted, this registry aims to fill specific gaps in understanding the heterogeneous nature of acute heart failure, making it a valuable addition to existing research.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Usual clinical presentation of acute heart failure as defined by the European Society of Cardiology : Gradual onset or new or worsening symptoms of rapid heart failure (eg, dyspnea, edema of the lower limbs and tiredness ) and signs of heart failure (eg elevation of jugular venous pressure, crackles, moving the shock peak) requiring urgent treatment. * Brain natriuretic peptide or value of brain natriuretic peptide (BNP) greater than 100 ng / L. Exclusion Criteria: * Inability or refusal to consent to participate in the study cohort.
Where this trial is running
Geneva
- Geneva University Hospitals — Geneva, Switzerland (Recruiting)
Study contacts
- Study coordinator: Sebastian Carballo, MD
- Email: sebastian.carballo@hcuge.ch
- Phone: +41223729216
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.